Neurologic disease: A modern pathophysiologic approach to diagnosis and treatment

Abstract

Dr. Meyer is Editor-In-Chief for NEUROLOGY INTERNATIONAL and currently serves as co-director of Neurosciences for the Guthrie Clinic after being the Medical Director for Neurology and Stroke Services for Sisters Hospital and the St. Joseph's Hospital Campus, Buffalo, NY. Dr. Meyer was a Principal Investigator for the NINDS tPA trial and co-authored the landmark New England Journal of Medicine article on tPA for acute stroke. Prior to directing Neurological Services for Tennova Health Care, Dr. Meyer was a member of the Acute Stroke Team for Catholic Health in Buffalo NY and had served as Chief of Neurology and Stroke Services for the Erie County Medical Center in Buffalo. As former Neurology Residency Program Director for the University at Buffalo School of Medicine where he served as Professor of Clinical Neurology and Nuclear Medicine, Dr. Meyer has trained and mentored numerous physicians in the field of Neurology. At the University of Michigan, Dr. Meyer studied GABA receptors in Alzheimer's Disease and concluded they were preserved, even in areas of dysfunctional posterior parietal cortex. As the Cole Neuroscience Foundation Investigator at the University of Tennessee, Dr. Meyer conducted some of the earliest studies on the use of PET in acute stroke, and developed techniques for PET radio-nuclide angiography, and made the first auto-radiographic demonstration of magnetic reduction of positron range, and later performed original research on the potential use of positron emitters for tumor radiotherapy.